ACCC

Search Drug Alphabetically

Generic Name	Bexarotene
Brand Name	Targretin®
Payment Category	Medicare Part D
Year Introduced	1999
Type of Drug	Retinoid X receptor activator
FDA-Approved Indication(s) For the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. (7/29/15)
Approved Indication(s) with Orphan Drug Status	Treatment of cutaneous T-cell lymphoma.
ICD-10 Code(s) for Labeled Indication(s)	Mature T/NK-cell lymphomas [C84.xx]

Name	Strength	Form	Package	Labeler	NDC